Diabetes
Diabetes
Diabetes Devices Market Reports
The diabetes medical device market encompasses many different categories and sub-categories, and the disease continues to be a major problem. Even though uncertainties continue to plague the healthcare system in the U.S., the market should continue to trend upward in the coming years.
iData Research produces diabetes devices market reports that are unmatched in their depth and accuracy, providing healthcare companies of all sizes the necessary intelligence to help them determine their most effective strategies.
Showing 1–8 of 26 results
-
US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 – MedView
US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 – MedView
The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets and lancing devices,... more... -
US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 – MedPro
US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 – MedPro
The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets and lancing devices,... more... -
US Market Report for Insulin Pumps 2017 – MedCore
US Market Report for Insulin Pumps 2017 – MedCore
Traditional insulin pumps, often referred to as durable pumps, offer constant and finer delivery of insulin to maintain precise control of glycemic levels. Traditional pumps feature a... more... -
US Market Report for Lancet and Lancing Devices 2017 – MedCore
US Market Report for Lancet and Lancing Devices 2017 – MedCore
A lancet is a small needle with a plastic or rubber coating that fits into the top of a lancing device. Lancing devices are pen-like instruments which are used in conjunction with a... more... -
US Market Report for Insulin Syringes 2017 – MedCore
US Market Report for Insulin Syringes 2017 – MedCore
Insulin is a protein and when administered orally, it degrades in the stomach and the intestines. When administered subcutaneously, it is better absorbed and has more of an effect on... more... -
US Market Report for Insulin 2017 – MedCore
US Market Report for Insulin 2017 – MedCore
Insulin is a hormone that causes glucose uptake from the blood through the cells of the liver, muscle and fat tissue to be stored as glycogen in the liver and muscle. Type 1... more... -
US Market Report for Continuous Glucose Monitoring 2017 – MedCore
US Market Report for Continuous Glucose Monitoring 2017 – MedCore
Continuous glucose monitoring (CGM) allows for a more accurate reading of how blood glucose levels fluctuate throughout the day by measuring interstitial glucose levels on a continuous... more... -
US Market Report for Blood Glucose Test Strips 2017 – MedCore
US Market Report for Blood Glucose Test Strips 2017 – MedCore
Blood glucose test strips are thin strips with enzymes that react to blood droplets. These create either a photometric or electrochemical response which is read by a glucose meter.... more...
Diabetes Care Devices Market Overview
iData delivers reports on a wide variety of topics, including the insulin market, the insulin pump market and much, much more. Devices we cover include the following:
- Blood glucose test strips
- Continuous glucose monitoring (CGM) systems
- Insulin pumps
- Insulin syringes
- Lancets and lancing devices
- Modern insulin pens
- Pen needles
- Traditional blood glucose meters
While there are many opportunities in the insulin pump market, as well as several other diabetes device markets, competition for healthcare funds continues to be fierce. Factors that support continued growth include the prevalence of age-related diseases, demographics and advances in technology. New products are being introduced on a regular basis, and scientific advances continue to progress exponentially.
Growth in the diabetes device market will continue to be driven by these advances, as well as the fact that the disease continues to be prevalent in the U.S. Limiting factors will include downward pressure on prices in areas such as the blood glucose test strip segment, changes in reimbursement, and others.
However, opportunities will also abound in the areas of diabetes treatment and prevention, which, thanks to the introduction of new therapies, look extremely promising.
Unassailable Analysis
iData’s diabetes devices market reports are compiled using industry-leading methodology. Our staff members dig deep into the industry, interviewing experts with medical associations as well as relevant company executives, researching economic and epidemiological studies, SEC filings and industry journals, and much more. We provide information on the latest trends and forces that executives and managers use when they need a comprehensive picture of where the market is currently and where it’s headed.
We provide a clear, up-to-date picture of the implications of the trends shaping the market, both in the U.S. and worldwide. Our reports also include in-depth discussion of the major players in the industry, as well as a thorough examination of activity regarding mergers and acquisitions. In addition, we have the tools and knowledge necessary to provide extensive sales forecasts for a wide variety of device categories.
Companies across the healthcare industry turn to iData for the deep research they need to make the most well-informed decisions possible. Our reports have helped established Fortune 500 companies, such as Johnson & Johnson, as well as emerging players alike, giving them the clearest, most actionable picture possible of the marketplace.
If you would like to learn more about our work in the diabetes medical device market or any of the other many areas we cover, please contact iData Research online or give us a call at 1 (866) 964-3282.
